USP33 Facilitates Retinoblastoma Growth by Deubiquitinating and Stabilizing EPHB2 Protein
Applied Biochemistry and Biotechnology · 2025-10 · 197 (10) · 6834-6848
DOI: 10.1007/s12010-025-05357-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, online erschienen am 18.08.2025. Verfasst von Jie Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, No. 569 XinSi Road, Xi'an, 710038, China. Jiejz_zhang@163.com. Hauptthemen laut MEDLINE: Receptor, EphB2, Retinoblastoma, Ubiquitination, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Retinoblastoma (RB) is an intraocular malignant tumor originating from primitive retinal stem cells or cone precursor cells, appearing most frequently under the age of three years. EPH receptor B2 (EPHB2) has been found to be involved in RB, but the potential action of EPHB2 in RB remains poorly understood. Real-time quantitative polymerase chain reaction and western blotting detected RNA levels and protein levels. Cell viability, proliferation, apoptosis, invasion, and stemness were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5-ethynyl-2'deoxyuridine flow cytometry, transwell, and sphere-forming assays. The interaction between EPHB2 and ubiquitin-specific protease 33 (USP33) was confirmed by cell ubiquitination and protein stability assays. Mouse xenograft models were utilized for the validation of the effect of the USP33/EPHB2 pathway in RB. EPHB2 was upregulated in RB, and lower overall survival was observed in patients with higher levels of EPHB2. Functional experiments demonstrated that EPHB2 promoted RB cell proliferation, invasion, and stemness, as well as inhibited RB cell apoptosis in vitro. Mechanically, USP33 is responsible for EPHB2 upregulation. Additionally, USP33 caused the deubiquitination and stabilization of EPHB2 protein. Rescue experiments showed that USP33 promoted RB growth in vitro and mouse models by activating the Wnt/β-catenin signaling in an EPHB2-dependent manner. The study identified a positive regulatory role of the USP33/EPHB2 pathway in the promotion of RB malignant behaviors, suggesting that developing USP33-specific inhibitors (such as small molecule compounds) may become a new direction for RB treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, No. 569 XinSi Road, Xi'an, 710038, China. Jiejz_zhang@163.com.
- Faculty of Hepatopancreatobiliary Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
- Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, No. 569 XinSi Road, Xi'an, 710038, China.
Zitieren
APA
Zhang, J., Nai, C., Wang, J., Su, L., Ning, X., & Guo, C. (2025). USP33 Facilitates Retinoblastoma Growth by Deubiquitinating and Stabilizing EPHB2 Protein. Applied Biochemistry and Biotechnology, 197(10), 6834-6848. https://doi.org/10.1007/s12010-025-05357-3
Vancouver
Zhang J, Nai C, Wang J, Su L, Ning X, Guo C. USP33 Facilitates Retinoblastoma Growth by Deubiquitinating and Stabilizing EPHB2 Protein. Applied Biochemistry and Biotechnology. 2025;197(10):6834-6848. doi:10.1007/s12010-025-05357-3
BibTeX
@article{Zhang2025,
author = {Zhang, Jie and Nai, Chao and Wang, Jue and Su, Liping and Ning, Xiaona and Guo, Chenjun},
title = {USP33 Facilitates Retinoblastoma Growth by Deubiquitinating and Stabilizing EPHB2 Protein},
journal = {Applied Biochemistry and Biotechnology},
year = {2025},
volume = {197},
number = {10},
pages = {6834--6848},
doi = {10.1007/s12010-025-05357-3}
}
EUVIMED